跳至主要内容
临床试验/TCTR20151206001
TCTR20151206001已完成未知

Blood aminophylline levels in infants with apnea of prematurity : comparing between pharmacokinetics dosing equation and standard dosage ; A pilot study

Faculty of Medicine Siriraj Hospital0 个研究点目标入组 30 人开始时间: 2015年12月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 Days 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1. Preterm infant less than or equal to 34 weeks gestation
  • 2. Attending physicians plan to start aminophylline indicated by
  • 2.1 apnea of prematurity
  • 2.2 prophylaxis for apnea of prematurity
  • 3. Parents understand Thai language
  • 4. Informed consent obtained

排除标准

  • 1. Infants with congenital neurological anomalies or chromosomal abnormality
  • 2. Infants whom apnea is due to other causes, e.g. sepsis
  • 3. infants who are receiving drugs which affect aminophylline level:- phenobarbital, phenytoin, erythromycin and propranolol
  • 4. Infants who received aminophylline within 7 days prior to the study
  • 5. infants with renal insufficiency diagnosed by
  • 5.1 urine output less than 1 ml/kg/hr within 12 hours prior to the study
  • 5.2 creatinine level more than or equal to 1.6 mg/dL for infants less than or equal to 27 weeks gestation
  • 5.3 creatinine level more than or equal to 1.1 mg/dL for infants 28-29 weeks gestation
  • 5.4 creatinine level more than or equal to 1 mg/dL for infants 30-32 weeks gestation
  • 6. Infants who have total bilirubin > 2 mg/dL or SGOT > 140 IU/L or SGPT > 50 IU/

研究者

相似试验